(Q27468944)
Statements
Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2–16 Years in Asia and Latin America (English)
0 references
1 October 2016
0 references
214
0 references
7
0 references
994-1000
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference